Metagenomi (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 27, 2022
- Vertical
- Gene Editing
- Funding URL
- View Funding Page
- Funding Amount:
- $175,000,000
Company Info
- Founders
- Brian C. Thomas
- Company Description
- Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms.
- Market
- Therapeutics
- Location
- Emeryville, California, USA
- Coinvestors
- Deep Track Capital, Eventide Asset Management, Farallon Capital Management, Frazier Healthcare Partners, Humboldt Fund, Marshall Wace, Millennium Management, PFM Health Sciences, Pura Vida Investments, RA Capital Management, Surveyor Capital